Concinnity

Concinnity Genetics is a biotechnology company developing RNA-based control systems that enable precise regulation of gene therapies after administration.

Its technology allows therapeutic gene expression to be modulated or reduced in response to side effects or clinical need, addressing a fundamental safety limitation of current gene and cell therapies.

The platform combines synthetic biology design with artificial intelligence to engineer control systems for integration into partner therapeutic programmes.